Ben Thrower, MD Clinical Instructor of Neurology Emory University Medical Director, Andrew C. Carlos Multiple Sclerosis Institute Shepherd Center Atlanta, GA
Neil S. Lava, MD Professor of Neurology Director, Multiple Sclerosis Clinic Emory University Atlanta, GA
J. Theodore Phillips, MD, PhD, FAAN Clinical Professor Department of Neurology University of Texas Southwestern Medical Center Research Investigator, Multiple Sclerosis Research Program Baylor Institute for Immunology Research Dallas, Texas
Mobile + Online on RealCME
Patient-Centered Approaches in the Continuum of Multiple Sclerosis Care
A 3-part Curriculum
CheckPoints: Kayla Visits 2 and 3
An estimated 350,000 to 500,000 people in the United States are currently diagnosed with multiple sclerosis (MS), a chronic neurologic disorder with potential for substantial negative impact on quality of life. Treatment is focused on returning function after an attack, preventing new attacks, and preventing disability. Neurologists and MS specialists play an important role in diagnosing and providing optimal treatment for patients with MS. However, the heterogeneity of the pathogenesis of MS and wide variation in the clinical course for each patient make management of MS challenging. Thus, the goal of this continuing education curriculum is to help neurologists and MS specialists build additional skills and competency in the use of evidence-based treatment approaches for patients with MS, ultimately leading to better patient outcomes.
Click here to download a patient education handout on the role of disease modifying therapies in MS. Program Developer/Facilitator
. Target Audience
This activity is designed for neurologists, nurse practitioners, physician assistants, and primary care physicians.
Upon completion of this educational activity, the participant should be able to:
Discuss current best practices in the management of common MS symptoms, such as depression, fatigue, cognitive dysfunction, and mobility impairment.
Ben Thrower, MD, has disclosed the following relevant financial relationships:
Served as an advisor or consultant for: Acorda Therapeutics; Biogen Idec, Inc.; Genzyme Corporation; Teva Neuroscience, Inc.
Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics; Biogen Idec, Inc.; Genzyme Corporation; Teva Neuroscience, Inc.
Neil Lava, MD, has no conflicts of interest to disclose.
J. Theodore Phillips, MD, has disclosed the following relevant financial relationships:
Received grant support from: Roche.
Served as a speaker or a member of a speakers bureau for: Acorda Therapeutics, Biogen Idec, Inc. Genzyme, and Sanofi.
Rick Ricer, MD, physician reviewer, has no conflicts of interest to disclose.
Susan P. Tyler, MEd, CCMEP, FACEHP, has no conflicts of interest to disclose.
Joshua Kilbridge, medical writer, has no conflicts of interest to disclose.
Kathleen Hines, MCM Education editorial director, has no conflicts of interest to disclose.
This activity has been planned and implemented in accordance with the Essentials Areas and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the University of Cincinnati and MCM Education. The University of Cincinnati is accredited by the ACCME to provide continuing medical education for physicians.
The University of Cincinnati designates this Enduring Material Activity for a maximum of 0.5 AMA PRA Category 1 Credit(s) ™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
University of Cincinnati
Continuing Medical Education
College of Medicine
3225 Eden Avenue, G24 Wherry Hall
Cincinnati, OH 45267
TERM OF OFFERING
This activity has a release date of January 23, 2014 and is valid for 1 year. Requests for credit must be received no later than January 23, 2015.
A review committee has agreed that this material can be completed in 30 minutes. This estimated study time in turn has determined the credit hours being offered.
INSTRUCTIONS FOR PARTICIPATING IN THIS ACTIVITY AND OBTAINING CME CREDIT
There are no fees for participating in and receiving CME credit for this online educational activity. By reviewing the course content and successfully completing the post-test and evaluation, clinicians are entitled to receive credit. The statement of credit will be available to print from your user history page.
- Read the learning objectives and faculty disclosures
- Participate in the activity
- Complete the post-test and activity evaluation
- Clinicians who successfully complete the post-test and evaluation will receive a CME certificate; successful completion is defined as a cumulative score of at least 60% correct
- All other participants who successfully complete the post-test and evaluation will receive a certificate of participation
ESTIMATED TIME TO COMPLETE
Commercial Support Statements
This activity is supported by an independent educational grant from Teva Neuroscience.
Commercial Support Guidelines
If any activity is supported by funds from a commercial source such as a pharmaceutical company or an equipment manufacturer it is very important that the Standards for Commercial Support are followed. In general, commercial entities may support CME activities through unrestricted grants. A commercial supporter may not exert undue influence in the form of determining content, choosing speakers, directly paying honoraria to faculty or paying registration fees of attendees. An acknowledgement of any educational support from a commercial company must appear in program brochures, syllabi, and other program materials. Certificate Fee
The opinions or views expressed in this CME activity are those of the presenters and do not necessarily reflect the opinions or recommendations of the University of Cincinnati, MCM Education, or the commercial supporter(s). Participants should critically appraise the information presented and are encouraged to consult appropriate resources for information surrounding any product, device, or procedure mentioned.